684 related articles for article (PubMed ID: 19502267)
21. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
Korendowych E; Owen P; Ravindran J; Carmichael C; McHugh N
Rheumatology (Oxford); 2005 Aug; 44(8):1056-60. PubMed ID: 15901902
[TBL] [Abstract][Full Text] [Related]
22. The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels.
Bos WH; Ursum J; de Vries N; Bartelds GM; Wolbink GJ; Nurmohamed MT; van der Horst-Bruinsma IE; van de Stadt RJ; Crusius JB; Tak PP; Dijkmans BA; van Schaardenburg D
Ann Rheum Dis; 2008 Sep; 67(9):1347-50. PubMed ID: 18388157
[TBL] [Abstract][Full Text] [Related]
23. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
24. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
Korkmaz C; Us T; Kaşifoğlu T; Akgün Y
Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
[TBL] [Abstract][Full Text] [Related]
25. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
26. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis.
Zhao J; Zhao Y; He J; Jia R; Li Z
J Rheumatol; 2008 Jun; 35(6):969-74. PubMed ID: 18398945
[TBL] [Abstract][Full Text] [Related]
28. [The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis].
Dijkmans BA; van Schaardenburg D; van der Horst-Bruinsma IE; Reesink HW; Vandenbroucke JP; Boers M
Ned Tijdschr Geneeskd; 2005 Mar; 149(13):688-93. PubMed ID: 15819133
[TBL] [Abstract][Full Text] [Related]
29. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
[TBL] [Abstract][Full Text] [Related]
30. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.
Ferucci ED; Majka DS; Parrish LA; Moroldo MB; Ryan M; Passo M; Thompson SD; Deane KD; Rewers M; Arend WP; Glass DN; Norris JM; Holers VM
Arthritis Rheum; 2005 Jan; 52(1):239-46. PubMed ID: 15641089
[TBL] [Abstract][Full Text] [Related]
31. Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis.
Shankar S; Grover R; Handa R
Indian J Med Res; 2006 Dec; 124(6):689-96. PubMed ID: 17287557
[TBL] [Abstract][Full Text] [Related]
32. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
33. Insights to clinical use of serial determination in titers of cyclic citrullinated peptide autoantibodies.
Kogure T; Tatsumi T; Fujinaga H; Niizawa A; Terasawa K
Mediators Inflamm; 2007; 2007():12367. PubMed ID: 17497027
[TBL] [Abstract][Full Text] [Related]
34. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis.
van Oosterhout M; Bajema I; Levarht EW; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2008 Jan; 58(1):53-60. PubMed ID: 18163491
[TBL] [Abstract][Full Text] [Related]
35. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
36. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides.
Pedersen M; Jacobsen S; Klarlund M; Pedersen BV; Wiik A; Wohlfahrt J; Frisch M
Arthritis Res Ther; 2006; 8(4):R133. PubMed ID: 16872514
[TBL] [Abstract][Full Text] [Related]
37. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.
Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI
J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660
[TBL] [Abstract][Full Text] [Related]
38. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
39. A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status.
Ball EM; Tan AL; Fukuba E; McGonagle D; Grey A; Steiner G; Bell AL; Rooney MR
Rheumatology (Oxford); 2014 Oct; 53(10):1835-43. PubMed ID: 24850876
[TBL] [Abstract][Full Text] [Related]
40. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis.
Christensen AF; Lindegaard H; Hørslev-Petersen K; Hetland ML; Ejbjerg B; Stengaard-Pedersen K; Jacobsen S; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; Pødenphant J; Østergaard M; Junker P
J Rheumatol; 2011 Aug; 38(8):1563-8. PubMed ID: 21572145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]